Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 17 Sept 2026 for Climb Bio, Inc., €1.2M. Read the official filing
Filing timeline
BuySaleStephen Basil Thomas
Insider track record
Disclosed buys
0
Disclosed sells
3
Signal history
Stephen Basil Thomas: trading record in brief
Stephen Basil Thomas is a declared insider of Climb Bio, Inc., with filings sourced from SEC (Form 4). Between 27 June 2024 and 15 September 2026, the trades on record add up to 8 filings.
On the market, this insider has only sold: 3 sales, €1.8M in total. The rest of the record consists of 2 share grants and 3 option exercises. Since January 2026: no purchases and 3 sales on the market.
The record was last updated on 17 September 2026 with an open-market sale (€1.2M) in Climb Bio, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Stephen Basil Thomas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
100,000 shares@ US$13.66820.20% mcap66.5% of flowCommon StockSEC:0001193125-26-394357:0
33,687 shares@ US$7.004611.3% of flowCommon StockSEC:0001193125-26-082533:0
90,000 shares@ US$5.233222.3% of flowCommon StockSEC:0001193125-26-054568:0
100,375 shares0Common StockSEC:0000950170-25-106563:0
25,094 sharesCommon StockSEC:0000950170-25-092273:0
25,093 sharesCommon StockSEC:0000950170-25-046083:0
50,188 sharesCommon StockSEC:0000950170-25-001176:0
103,907 sharesCommon StockSEC:0000950170-24-078685:0
8 of 8 declarations
